Zhou, Shuangshuang, Meiyi Deng, Xuyu Bian, Jindong Shi, Rongrui Liang, and Min Tao. 2024. “Synergistic Anti-Tumor Effects of Lenalidomide and Gefitinib by Upregulating ADRB2 and Inactivating the mTOR/PI3K/AKT Signaling Pathway in Lung Adenocarcinoma: Role of ADRB2 and mTOR/PI3K/AKT in LUAD”. Cellular and Molecular Biology 70 (2):120-27. https://doi.org/10.14715/cmb/2024.70.2.17.